Dyne Therapeutics Inc (NASDAQ:DYN) stock climbed 3.6% following the announcement that the U.S. Food and Drug Administration ...

July marks a transformative month in oncology with the FDA's groundbreaking approvals and updates, enhancing treatment ...

Liberals promised to ‘significantly reduce’ wait times for pharmaceuticals, which it acknowledged were longer than in other ...

United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration. As previously disclosed, the Company's Investigational Device ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...

Health Canada is supposed to issue rulings on new generics – which are copies of branded drugs whose patents have expired – ...

The Food and Drug Administration (FDA) has issued another Complete Response Letter (CRL) to Regeneron (CRL) for the Biologics License Application (BLA) for odronextamab in relapsed/refractory ...

If Telix can crack a better therapy for key cancers in its remit, its $7 billion market valuation looks only the start, ...

After decades of strong federal support for scientific research, the US government is now proposing deep cuts. Here’s what ...

Covered visa applicants will be required to post a bond of up to $15,000, but the State Department gave consular officers ...

Trump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but the ...